Oncology Discovery Posts Optimizing for Luck in Drug Development Continue readingOptimizing for Luck in Drug Development Comments closed An Immuno-Oncology Target You’ve (Probably) Never Heard of – Releasing the Brakes on the Innate Immune System Continue readingAn Immuno-Oncology Target You’ve...
Drug discovery is becoming slower and more expensive over time $2.7Bn Median cost of bringing an oncology or immunology drug to market >13yrs Time to bring a drug to market 90% High attrition rate results in only 10% of drugs reaching the market ...
Discovery research is the first step in transforming innovative ideas into groundbreaking therapies. At its core are two key pillars: Chemistry and Biologics, are both essential for understanding diseases and developing effective treatments. With a world-class team, cutting-edge facilities, and a passi...
Caris has the tools and data to help you identify, develop and commercialize your next oncology targets. Despite transformational breakthroughs in our understanding of disease, drug development has focused on a redundant, limited number of targets. Caris Discovery is an indication and modality-agnostic...
Oncology Treatment Discovery Current Archives About SubmissionsLogin or Register to make a submission. Submission Preparation Checklist As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned ...
Featured Publication MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. J Exp Med(2023) 220 (11): e20211743. Bhin et al., View Abstract TruncatedFGFR2is a clinically actionable oncogene in multiple cancers. ...
“We would like to thank the [Perceptive] Medical Imaging team very much for your contribution to this wonderful (oncology) study outcome. Without you, this [marketing authorization] would have never been possible.” MEDICAL LEAD Top 10 Global Pharmaceutical Company ...
Caris Discovery Unlock truly novel targets for your discovery pipeline Caris has the tools and data to help you identify, develop and commercialize your next oncology targets. Despite transformational breakthroughs in our understanding of disease, drug development has focused on a redundant, limited ...
“We would like to thank the [Perceptive] Medical Imaging team very much for your contribution to this wonderful (oncology) study outcome. Without you, this [marketing authorization]would have never been possible.” MEDICAL LEADTop 10 Global Pharmaceutical Company ...
Pharmidex delivers translational solutions with CNS, oncology, respiratory, DMPK, drug discovery, and ADMET/pharmacokinetics expertise.